← The SEC Ephemeris: the whole map
Shilpa Medicare Limited bortezomib
In the graph: all 4 documents (10 pages).
- Application
- NDA 212782
- Ticker
- Shilpa Medicare Limited
- Product
- bortezomib
- Disease area
- Not yet classified
- Response path
- Not yet classified
- Complete Response Letters
- August 1, 2023 · April 14, 2022 · June 24, 2021 · March 10, 2020
From FDA letters and SEC filings. Not investment or medical advice.